Literature DB >> 10818505

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

M O McCarron1, J A Nicoll.   

Abstract

Following the identification of the role of the apolipoprotein E (APOE) gene polymorphism in Alzheimer's disease (AD), this gene was examined in cerebral amyloid angiopathy (CAA). As in AD, the APOE epsilon 4 allele was found to be associated with CAA. Lobar intracerebral hemorrhage is the major clinical manifestation of CAA. Initial studies on a small number of patients with CAA-related hemorrhage (CAAH) identified overrepresentation of APOE epsilon 4. However, it became clear that confounding bias from concomitant AD and the need for pathologically confirmed cases of CAAH would also have to be considered. A larger series of pathologically confirmed cases of CAAH, also assessed for AD pathology, found a surprising overrepresentation of the APOE epsilon 2 allele. Because of the association between CAA and AD, it might have been predicted that patients with CAAH would have a low, rather than a high, epsilon 2 frequency. The overrepresentation of APOE epsilon 2 was present both in patients with and without AD, whereas a high epsilon 4 frequency correlated with concomitant AD. Further studies found that overrepresentation of APOE epsilon 2 is specific for CAAH and is not found in intracranial hemorrhages due to other causes. In CAAH, APOE epsilon 2 may interact with putative risk factors for hemorrhage, including antiplatelet/anticoagulant medication, minor head trauma, and hypertension. Several microvascular abnormalities in amyloid-laden blood vessels have been assumed to antedate CAAH and increase its likelihood. APOE epsilon 2 has now been found to be associated with some of these vascular abnormalities, specifically a "double-barrel" appearance and fibrinoid necrosis. The currently favored interpretation is that APOE epsilon 4 enhances deposition of amyloid-beta protein in the walls of cerebral blood vessels, whereas epsilon 2 is a risk factor for hemorrhage from amyloid-laden blood vessels by promoting specific "CAA-associated vasculopathies."

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818505     DOI: 10.1111/j.1749-6632.2000.tb06366.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

Review 3.  Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

Authors:  Mushtaq Wani; Emma Nga; Ranjini Navaratnasingham
Journal:  BMJ       Date:  2005-08-20

Review 4.  Advances in the management of intracerebral hemorrhage.

Authors:  Opeolu Adeoye; Joseph P Broderick
Journal:  Nat Rev Neurol       Date:  2010-09-28       Impact factor: 42.937

5.  Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.

Authors:  Gaël Nicolas; David Wallon; Claudia Goupil; Anne-Claire Richard; Cyril Pottier; Véronique Dorval; Mariana Sarov-Rivière; Florence Riant; Dominique Hervé; Philippe Amouyel; Maelenn Guerchet; Bebene Ndamba-Bandzouzi; Pascal Mbelesso; Jean-François Dartigues; Jean-Charles Lambert; Pierre-Marie Preux; Thierry Frebourg; Dominique Campion; Didier Hannequin; Elisabeth Tournier-Lasserve; Sébastien S Hébert; Anne Rovelet-Lecrux
Journal:  Eur J Hum Genet       Date:  2015-04-01       Impact factor: 4.246

6.  Distribution and effect of apo E genotype on plasma lipid and apolipoprotein profiles in overweight/obese and nonobese Chinese subjects.

Authors:  Juan Zhang; Ping Fan; Rui Liu; Yi Huang; Shanshan Liang; Yu Liu; Yin Wu; Huai Bai
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

7.  Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Authors:  D M O Pruissen; F R Rosendaal; J W Gorter; A A Garcia; L J Kappelle; A Algra
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

8.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.

Authors:  Ricardo S Osorio; Indu Ayappa; Janna Mantua; Tyler Gumb; Andrew Varga; Anne M Mooney; Omar E Burschtin; Zachary Taxin; Emmanuel During; Nicole Spector; Milton Biagioni; Elizabeth Pirraglia; Hiuyan Lau; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; David M Rapoport; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

9.  Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Authors:  Johannes Attems; Florían Lauda; Kurt A Jellinger
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

Review 10.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.